11 – 20 of 39
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1995
-
Mark
A Phase I/II Evaluation of Metoclopramide as a Radiosensitiser in Patients with Inoperable Squamous Cell Carcinoma of the Lung
(
- Contribution to journal › Article
- 1994
-
Mark
Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. South Sweden Breast Cancer Group
(
- Contribution to journal › Article
-
Mark
ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer
(
- Contribution to journal › Article
- 1993
-
Mark
Comparative cytogenetic and DNA flow cytometric analysis of 150 bone and soft-tissue tumors
(
- Contribution to journal › Article
- 1992
-
Mark
One or multiple samplings for flow cytometric DNA analyses in breast cancer-prognostic implications?
(
- Contribution to journal › Article
-
Mark
Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas--a 10 year survival study
(
- Contribution to journal › Article
-
Mark
Comparison of BrdUrd and [3H]TdR incorporation to estimate cell proliferation, cell loss, and potential doubling time in tumor xenografts
(
- Contribution to journal › Article
-
Mark
Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome
(
- Contribution to journal › Article
-
Mark
Prognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas
(
- Contribution to journal › Article
-
Mark
Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry
(
- Contribution to journal › Article